Healthcare

According to a market report by Lucintel, the future of the stem cell manufacturing market looks promising with opportunities in the pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes. The global stem cell manufacturing market is expected to reach an estimated $6.3 billion by 2028 with a CAGR of 9.7% from 2023 to 2028. The major drivers for this market are increasing prevalence of genetic diseases and growing consumer awareness towards therapeutic efficacy of stem cell products.



In this market, adult stem cell, human embryonic stem cell, induced pluripotent stem cell, and very small embryonic like stem are the major segments of stem cell manufacturing market by product. Lucintel forecasts that adult stem cell will remain the largest segment over the forecast period due to the increasing usage of these cells helps in preventing embryonic damage and transplant rejection. 



Within this market, pharmaceutical and biotechnology companies are expected to remain the largest segment due to the increasing clinical studies for chronic diseases and growing private investment in stem cell-based research.



North America will remain the largest region due to availability of advanced research infrastructure, increasing government initiative for advancing stem cell therapies, and presence of market leaders in the region.

Advanced Cell, STEMCELL, Cellular Engineering, CellGenix, and PromoCell are the major suppliers in the global stem cell manufacturing market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global stem cell manufacturing market by product, application, technology, therapy, end use, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Stem Cell Manufacturing Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global stem cell manufacturing market by product, application, technology, therapy, end use, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the stem cell manufacturing market by product (adult stem cell, human embryonic stem cell, induced pluripotent stem cell, and very small embryonic like stem), application (regenerative medicine and drug discovery & development), technology (cell acquisition, cell production, cryopreservation, and expansion & sub-culture), therapy (autologous and allogenic), end use (pharmaceutical & biotechnology companies, hospitals & cell banks, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?